Natus Medical (BABY) is a case in point as to why I'm always skeptical around growth stories built on rampant M&A activity, particularly when those growth stories are awarded the sort of multiples that go with the strongest organic growth names in the med-tech space. To that end, while Natus had a career-making run through the first decade of this century, the going has gotten a lot tougher post-2008, during which time Natus has lagged another famous (or infamous) growth-by-acquisition story Integra Lifesciences (IART) and other less-than-stellar performers like Medtronic (MDT).
Please read more here:
Baby, Baby, Where Has The Love Gone?
Seeking Alpha: Baby, Baby, Where Has The Love Gone?
0 comments:
Post a Comment